In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: The GISIA-2 study

Journal of Chemotherapy

Volumn 19, Issue 5, 2007, Pages 508-513

  Morace, Giulia ^a   Drago, M ^a   Scaltrito, M M ^a   Conti, S ^b   Fanti, F ^b   Polonelli, L ^b   Amato, G ^c   Piccirillo, M ^c   Belli, M C M ^c   Andreoni, S ^d   Fanello, R ^d   Barbaro, P ^e   Petraroli, C ^e   Bistoni, F ^f   Mencacci, A ^f   Pitzurra, L ^f   Cione, P ^g   Cuccurullo, S ^g   Fadda, G ^h   Sanguinetti, M ^h   Fontana, R ⁱ   Lo Cascio, G ⁱ   Goglio, A ^j   Farina, C ^j   Lombardi, G ^k   Coli A ^k   Manso, E ^l   Paladini, C ^l   Marone, P ^m   Cavanna, C ^m   Menozzi, M ⁿ   Di Stefano, E ⁿ   Montagna, M T ^o   Napoli, C ^o   Tato D ^o   Nanetti, A ^p   Nicoletti, P L ^q   Pecile, P ^q   Oliveri, S ^r   Buscema, G ^r   Rigoli, R ^s   Niero, M ^s   Sanna, M ^t   Podda, R ^t   Porcu, P P ^t   Schito, G C ^u   Soro, O ^u   Viviani, M A ^a   Tortorano, A M ^a   La Face, S ^v   Mancuso, I ^v   more..

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

^d MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^e Ospedale Morelli   (Italy)

^f UNIVERSITY OF PERUGIA   (Italy)

^g MONALDI HOSPITAL   (Italy)

^h CATHOLIC UNIVERSITY   (Italy)

ⁱ UNIVERSITY OF VERONA   (Italy)

^j OSPEDALI RIUNITI   (Italy)

^k OSPEDALE DI CIRCOLO   (Italy)

^l Ospedale Le Torrette   (Italy)

^m FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

ⁿ VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^o UNIVERSITY OF BARI   (Italy)

^p UNIVERSITY OF BOLOGNA   (Italy)

^q CAREGGI UNIVERSITY HOSPITAL   (Italy)

^r UNIVERSITY OF CATANIA   (Italy)

^s OSPEDALE CA FONCELLO   (Italy)

^t Ospedale Oncologico A Businco   (Italy)

^u UNIVERSITY OF GENOA   (Italy)

^v PFIZER INC   (United States)

more..

Author keywords

Amphotericin B; Itraconazole; MIC MFC; Mould susceptibility; Voriconazole

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; CONTROLLED STUDY; DILUTION; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN;

EID: 36549071984     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.5.508     Document Type: Article

References (14)

1. Bille J, Marchetti O, Calandra T. Chancing face of health-care associated fungal infections. Curr Opin Infect Dis 2005; 18: 314-319.
2. Clark TA, Hajjeh RA. Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 2002; 15: 569-574.
3. Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis 2005; 41: 521-526.
4. Denning DW, Radford SA, Oakley KL, Johnson EM, WarnockDW. Correlation between in vitro susceptibility testing to itraconazole and in vivo clinical outcome of Aspergillus fumigatus infection. J Antimicrob Chemother 1997; 40: 401-414.
5. Ghannoum MA, Rex JR, Galgiani JN. Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J Clin Microbiol 1996; 34: 489-495.
6. Espinel-Ingroff A. Utility of mould susceptibility testing. Curr Opin Infect Dis 2003; 16: 527-532.
7. Pfaller MA, Messe SAr, Hollis RJ, Jones RN, The Sentry Participants Group. Antifungal activity of posoconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY antimicrobial surveillance program. 2000. Antimicrob Agents Chemother 2002; 46: 1032-1037.
8. Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999; 12: 40-79.
9. Jeu LA, Piacenti FC, Lyakhovetskiy AG, Fung HB. Voriconazole. Clin Ther 2003; 25: 1321-1381.
10. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: Approved Standard, M38-A. 2002; NCCLS, Wayne, PA.
11. Castro C, Serrano MC, Flores B, Espinel-Ingroff A, Martin-Mazuelos E. Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus species. J Clin Microbiol 2004; 42: 4358-4360.
12. Drago M, Scaltrito MM, Cariani L, Morace G. In vitro testing of Aspergillus fumigatus clinical isolates for susceptibility to voriconazole, amphotericin B and itraconazole: comparison of Sensititre versus NCCLS M38-A using two different inocula. J Chemother 2004; 16: 474-478.
13. Espinel-Ingroff A, Bartlett M et al. Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp: NCCLS collaborative evaluation. Antimicrob Agents Chemother 2001; 45: 1828-1835.
14. Denning DW. Echinocandin antifungal drugs. Lancet 2003; 362: 1142-1151.